# OnCo record zeta (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/zeta/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "zeta", "NCT00410761" ;
  schema:name "ZETA"@en ;
  schema:description "ZETA showed that vandetanib, a pill blocking the RET protein that drives most medullary thyroid cancers along with the tumour blood supply, kept advanced disease from growing for much longer than placebo, and it became the first drug ever approved for this rare cancer."@en ;
  schema:url <https://onco.cc/trials/zeta/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00410761> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/medullary-thyroid-cancer/>, <https://onco.cc/cancers/thyroid/> ;
  onco:drugs <https://onco.cc/drugs/vandetanib/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/>, <https://onco.cc/companies/sanofi/> ;
  onco:people <https://onco.cc/people/samuel-wells/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-zeta-vandetanib-mtc-wells-jco-2012/> .